Published Date: Feb-19
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Cataract Surgery Devices Market, published by KBV research, the LAMEA Cataract Surgery Devices Market would witness market growth of 5.7% CAGR during the forecast period (2018 – 2024).
The Hospitals market would dominate the LAMEA Cataract Surgery Devices Market by End User 2024; growing at a CAGR of 5.1 % during the forecast period. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 6.8% during (2018 - 2024).
The Brazil market dominated the LAMEA Intraocular Lens (IOL) Market by Country 2017, thereby, achieving a market value of $44.1 million by 2024. The Argentina market is expected to witness a CAGR of 7% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 5.8% during (2018 - 2024).
The Consumables market dominated the Saudi Arabia Cataract Surgery Devices Market by Type 2017, growing at a CAGR of 5.5 % during the forecast period. The Equipment market is expected to witness highest CAGR of 6.5% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Novartis Ag, Abbott Laboratories, Carl Zeiss Meditec Ag, Essilor International S.A, Johnson & Johnson, Metall Zug AG, Topcon Corporation, Nidek Co., Ltd, Valeant Pharmaceuticals International, Inc. and Ziemer Ophthalmic Systems Ag.
LAMEA Cataract Surgery Devices Market Segmentation
By End User
Unique Offerings from KBV Research